Clinical Trial Update: Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial [NA]

View source ↗

Summary

Clinical trial update for the Fasting Mimicking Diet combined with immune checkpoint inhibitors (FMD-ICI) to reduce immune-related adverse events in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Neoplasm

Drugs mentioned

• immune checkpoint inhibitors (ICIs)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Malignant Solid Neoplasm | NA | Status: RECRUITING